News

The DOJ has accused CHEST and other medical journals of scientific bias, demanding responses to a list of questions by May 2, 2025.
At least three medical journals have received letters from a top federal prosecutor questioning whether they mislead readers ...
The Mediterranean Neuroscience Society Conference 2025The clinical and research landscape around medical cannabis has evolved dramatically in the past two ...
the medical journal of the American Academy of Neurology. Physicians classify brain tumors and determine treatment options, in part, by the genes they express. According to World Health ...
A Russian scientist who works at Harvard University’s Medical School has spent the last six weeks in immigration detention and is facing possible deportation after undeclared frog embryo samples ...
Medical Journal Article Urges Mass Propaganda Campaign Against Fossil Fuels The Trump Administration’s Gamesmanship Is the Reason for This Weekend’s Frenetic Litigation Supreme Court Orders ...
TG Therapeutics, Inc. NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the publication of two journal articles one describing the evolution of CD20 ...
Miami-based Ayr Wellness has reported another leadership change. The medical marijuana chain announced interim CEO Steven M. Cohen stepped down from that role. Ayr's board of directors appointed ...
Data sources We selected the three highest-ranked journals from the ‘Medicine—General and Internal’ category including the Journal of the American Medical Association (JAMA), The Lancet and The New ...
If you deviated from the plan (common and acceptable with a reasonable explanation) transparently report it and why. Many journals require that you upload the trial protocol as a supplemental file to ...
Abstract: With the rapid development of technologies such as Artificial Intelligence (AI), edge computing, and cloud intelligence, the medical field is undergoing a fundamental transformation [1].
Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting ...